The first comprehensive review of evidence for the use of cannabis-based medicinal products (CBMPs) to treat epilepsy has been published in the UK.
Friday (November 1) marks the sixth anniversary of the legalisation of medicinal cannabis in the UK, but many children with epilepsy are still being denied access to it via the National Health Service (NHS) due to a ‘lack of evidence’.
To plug that gap, Maple Tree Consultants – co-founded by campaigner Hannah Deacon and Professor Mike Barnes, the first doctor to prescribe the medicine in the UK – has published Medical Cannabis & Epilepsy.
Continue reading...
Last edited by a moderator:
